Andrew , M.d., Ph.d.
Territory Manager
pharmaceutical
Takeda
Philippines
Biography
In 2015, Andrew Plump, M.D., Ph.D., joined Takeda as Chief Medical and Scientific Officer (CMSO). Dr. Plump also serves as a member of Takeda’s Executive Team and of the company’s Board of Directors. In his position, he leads Takeda’s global Research & Development organization, where he provides strategic direction and oversight.
Research Interest
Dr. Plump also spent more than 10 years at Merck in a Clinical Pharmacology group, working on programs in neurodegeneration, immunology, metabolism and infectious diseases. Following additional roles focusing on early development, genomics and biomarkers, particularly in cardiovascular and metabolism, he assumed the position of Vice President, Worldwide Cardiovascular (CV) Research Head. In this role, he had direct responsibility for preclinical development and research teams, and a leadership role in the end-to-end activities of the Merck cardiovascular portfolio. Together with his team, he helped discover and support a pipeline of novel therapies in atherosclerosis, vascular diseases and thrombosis.
